ATA21475A - METHOD FOR PRODUCING INFLUENZAVIRUS COMPONENTS - Google Patents

METHOD FOR PRODUCING INFLUENZAVIRUS COMPONENTS

Info

Publication number
ATA21475A
ATA21475A AT21475A AT21475A ATA21475A AT A21475 A ATA21475 A AT A21475A AT 21475 A AT21475 A AT 21475A AT 21475 A AT21475 A AT 21475A AT A21475 A ATA21475 A AT A21475A
Authority
AT
Austria
Prior art keywords
influenzavirus
producing
components
producing influenzavirus
influenzavirus components
Prior art date
Application number
AT21475A
Other languages
German (de)
Other versions
AT345449B (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA21475A publication Critical patent/ATA21475A/en
Application granted granted Critical
Publication of AT345449B publication Critical patent/AT345449B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AT21475A 1974-01-14 1975-01-13 METHOD FOR PRODUCING INFLUENZAVIRUS COMPONENTS AT345449B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
ATA21475A true ATA21475A (en) 1978-01-15
AT345449B AT345449B (en) 1978-09-11

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT21475A AT345449B (en) 1974-01-14 1975-01-13 METHOD FOR PRODUCING INFLUENZAVIRUS COMPONENTS

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
ES2359214T5 (en) * 2005-11-01 2014-10-08 Novartis Vaccines And Diagnostics Gmbh Viral vaccines derived from cells with reduced levels of residual cellular DNA by treatment with beta-propiolactone
SI2192917T1 (en) * 2007-08-28 2014-05-30 Baxter International Inc. Method for producing viral vaccines
EP3068791B1 (en) 2013-11-15 2020-07-29 Novartis AG Removal of residual cell culture impurities

Also Published As

Publication number Publication date
FR2257305B1 (en) 1982-03-19
DD116239A5 (en) 1975-11-12
ZA75259B (en) 1976-08-25
AU500250B2 (en) 1979-05-17
IE40794L (en) 1975-07-14
JPS50100224A (en) 1975-08-08
NO143128B (en) 1980-09-15
NL166622C (en) 1981-09-15
NL166622B (en) 1981-04-15
DK1475A (en) 1975-09-01
FI750014A (en) 1975-07-15
IE40794B1 (en) 1979-08-15
SU616997A3 (en) 1978-07-25
SE427238B (en) 1983-03-21
NO750031L (en) 1975-08-11
JPS58407B2 (en) 1983-01-06
HU173920B (en) 1979-09-28
DE2500785A1 (en) 1975-07-31
DE2500785B2 (en) 1980-01-03
SE7500130L (en) 1975-07-15
ES433759A1 (en) 1977-02-16
BE824372A (en) 1975-07-14
AU7730575A (en) 1976-07-15
YU5875A (en) 1984-04-30
DK140003C (en) 1979-10-29
PH14458A (en) 1981-07-29
DE2500785C3 (en) 1980-09-11
FR2257305A1 (en) 1975-08-08
IL46426A0 (en) 1975-04-25
FI54053B (en) 1978-06-30
GB1498261A (en) 1978-01-18
JPS56127319A (en) 1981-10-06
HK56380A (en) 1980-10-16
DK140003B (en) 1979-06-05
CH589453A5 (en) 1977-07-15
CA1049406A (en) 1979-02-27
MY8100204A (en) 1981-12-31
NO143128C (en) 1980-12-29
IL46426A (en) 1978-01-31
FI54053C (en) 1978-10-10
JPS6035326B2 (en) 1985-08-14
CS191254B2 (en) 1979-06-29
NL7500301A (en) 1975-07-16
YU41289B (en) 1987-02-28
PL93689B1 (en) 1977-06-30
AT345449B (en) 1978-09-11

Similar Documents

Publication Publication Date Title
AT351008B (en) METHOD FOR PRODUCING MERCAPTANES
AT335995B (en) METHOD FOR PRODUCING KETOISOPHORONE
AT370714B (en) METHOD FOR PRODUCING ALDEHYDES
AT336633B (en) METHOD FOR PRODUCING MONOMETHYLTIN TRIHALOGENIDES
AT338232B (en) METHOD FOR PRODUCING KETOISOPHORONE
AT342015B (en) METHOD FOR PRODUCING ACETOACETAMIDE-N-SULFOFLUORIDE
AT345449B (en) METHOD FOR PRODUCING INFLUENZAVIRUS COMPONENTS
AT329586B (en) METHOD FOR PRODUCING ORGANOPHOSPHINES
AT344136B (en) METHOD FOR PRODUCING NEW 2-DEUTERO-3-FLUOR-DL-ALANINE
ATA425375A (en) METHOD FOR PRODUCING PROSTAGLANDINE-LIKE (D1) COMPOUNDS
DD130933A5 (en) METHOD FOR PRODUCING SULFINYLAZETIDINONES
AT349487B (en) METHOD FOR PRODUCING SYMMETRIC UREAS
AT360491B (en) METHOD FOR PRODUCING HEXAGONAL BORNITRIDE
AT351523B (en) METHOD FOR PRODUCING 2-ALKYL-5-NITROIMIDAZOLE DERIVATIVES
AT335609B (en) METHOD FOR PRODUCING CEPHEM CONNECTIONS
AT352303B (en) METHOD FOR PRODUCING MONO-O-BETA-HYDROXYAETHYL-7-RUTIN
AT338748B (en) METHOD FOR MANUFACTURING ACETOXYBUTANALS
AT338253B (en) METHOD FOR PRODUCING DIAMIDES
AT343131B (en) METHOD FOR PRODUCING POLY- (N-ALKYLIMINOALANES)
AT340885B (en) METHOD FOR PRODUCING ACETOACETAMIDE-N-SULFOFLUORIDE
AT387375B (en) CONTINUOUS METHOD FOR PRODUCING CHLORDIOXIDE
AT340589B (en) METHOD FOR PRODUCING DELTA3 CEPHALOSPORINESTERS
AT342063B (en) METHOD FOR PRODUCING 1-PHENYL-4-AMINO-5-CHLORO-PYRIDAZONE (6)
AT374824B (en) METHOD FOR PRODUCING DETERGENT POWDERS
ATA625774A (en) METHOD FOR PREPARING PHENYLPYRIDAZONES

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
UEP Publication of translation of european patent specification
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee